Navigation Links
Jules Musing to Lead Business Development Effort
Date:12/7/2011

NEWARK, Del., Dec. 7, 2011 /PRNewswire/ -- iBio, Inc. (NYSE AMEX: IBIO) today announced that Jules A. Musing, an iBio Director, will assume a role as a Managing Director of the Company for at least the next six months in order to accelerate the Company's business development activity.  Mr. Musing, formerly a Senior Executive at Johnson & Johnson, joined iBio's Board of Directors in June of 2011.  In the course of his career in the Pharmaceutical and Biotechnology Industry, Mr. Musing has been President and Managing Director for Johnson & Johnson, Janssen Pharmaceutica, and Ares Serono companies.  At Johnson & Johnson, Mr. Musing was also responsible for worldwide licensing and acquisition of pharmaceutical and biotechnology products and technologies and the establishment of strategic alliances.  His activities included the establishment of new scientific and product collaborations in various therapeutic areas, the negotiation of licensing and alliance agreements with biotechnology and pharmaceutical companies worldwide, and the partnering, spin-out and out-licensing of company pharmaceutical and biotechnology assets.

In his role as an iBio Managing Director, Mr. Musing will focus on the Company's business development and licensing activities, including direct dealings with third parties and development of human and material resources to enlarge the Company's business development capacity.

"Jules will help us expand our business development capability rapidly to deal with the product candidates already developed on our platform and those we expect in the next few months," said Robert B. Kay, iBio's Chairman and CEO.  "We expect Jules' experience as a deal maker and his access to senior management in potential users of our technologies to lead to important business opportunities for us in a variety of U.S. and internationa
'/>"/>

SOURCE iBio, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Kronos Announces First Quarter Business Update and Financial Results
2. Growth Achieved in Spherixs Health Sciences Consulting Business
3. ImaRx Therapeutics Transitions Business Strategy
4. Argonauta Communications Certified as Women-Owned Business by the Womens Business Enterprise National Council (WBENC)
5. New Pharma Business Model Increases Pressure on Staff Communicating Trial Data
6. Small Business Innovation Research Program Awards Grant to Biomoda
7. American Dairy Provides Business Update
8. Synvista Therapeutics Announces Termination of Clinical Trials of Alagebrium and SYI-2074 and Provides Business Update
9. Pharmos Issues Business Update on Dextofisopam Trial and Financing
10. One Call Now Offers Notification Service at NO CHARGE for Governments, Schools, Businesses, Religious Organizations and Others in Response to Swine Flu Outbreak
11. Encorium Group Provides Update to LOI with Respect to the Sale of its U.S. Business
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/26/2015)... , March 26, 2015  The new Phonak CROS ... the unaidable ear to a Venture hearing aid worn on ... to hear speech from the side they could not hear ... is as easy and intuitive as a normal binaural fit, ... solution during the fitting session.    "Fitting single-sided ...
(Date:3/26/2015)... ATHENS, Ohio , March 26, 2015  An Ohio ... over their own medical records.  As CEO for a start-up ... Reid is launching a new business that will empower ... a quantum leap over today,s insecure methods. ... Secure Exchange of Encrypted Data – will enable people to ...
(Date:3/26/2015)... , March 26, 2015  CNBC profiled MJ Freeway ... part of a series "How I Did It," which features ... the High Road" released yesterday, illustrates how two tech ... leading IT providers to the marijuana industry. ... describes how Co-Founders Amy Poinsett and Jessica Billingsley ...
Breaking Medicine Technology:Phonak CROS II: The smart solution for single-sided deafness 2Ohio Entrepreneur Develops Technology that Allows Patients Control Over Their Healthcare Records 2Ohio Entrepreneur Develops Technology that Allows Patients Control Over Their Healthcare Records 3Ohio Entrepreneur Develops Technology that Allows Patients Control Over Their Healthcare Records 4MJ Freeway, Industry-Leading Software Solution for Cannabis Businesses, Featured in CNBC Special "How I Did It" 2
... 3, 2011 NxStage® Medical, Inc. (Nasdaq: ... today reported record financial results for the second quarter ... well above the top end of its guidance range. ... the second quarter of 2011 increased to $53.8 million, ...
... Silence Therapeutics plc (AIM: SLN) ("Silence" or the "Company"), ... that the United States Patent and Trademark Office has ... patent application directed to the fundamental technology involved in ... delivery systems. The allowable subject matter is directed to ...
Cached Medicine Technology:NxStage Reports Record Second Quarter 2011 Financial Results and Raises Revenue Guidance for 2011 2NxStage Reports Record Second Quarter 2011 Financial Results and Raises Revenue Guidance for 2011 3NxStage Reports Record Second Quarter 2011 Financial Results and Raises Revenue Guidance for 2011 4NxStage Reports Record Second Quarter 2011 Financial Results and Raises Revenue Guidance for 2011 5NxStage Reports Record Second Quarter 2011 Financial Results and Raises Revenue Guidance for 2011 6NxStage Reports Record Second Quarter 2011 Financial Results and Raises Revenue Guidance for 2011 7NxStage Reports Record Second Quarter 2011 Financial Results and Raises Revenue Guidance for 2011 8Silence Therapeutics Receives Notice of Allowance for New U.S. Patent Covering Novel Small Interfering RNA (siRNA) Delivery Technology 2Silence Therapeutics Receives Notice of Allowance for New U.S. Patent Covering Novel Small Interfering RNA (siRNA) Delivery Technology 3Silence Therapeutics Receives Notice of Allowance for New U.S. Patent Covering Novel Small Interfering RNA (siRNA) Delivery Technology 4
(Date:3/26/2015)... 2015 Los Lunas, N.M., resident Lyndsi ... until last year, when she attended a pageant and ... (PH) – a debilitating disease of the lungs that ... to right-heart failure. The disease turned the Alderete’s world ... entered the pageant to raise awareness about her daughter’s ...
(Date:3/26/2015)... LinkToBanking, a Preferred Partner Network ... Fleming as Chairman of the Board and Robert ... With their combined knowledge and experience in ... Fleming and Mr. Casares will provide exceptional guidance ... related businesses. , About Tom Fleming, Mr. Fleming, ...
(Date:3/26/2015)... 2015 The Van Nuys dentists ... they are offering a new patient special to welcome new ... among the best ways to protect dental health, but patients ... more likely to delay or avoid these checkups. This special ... need at an affordable price. The dentists at Hamlin Dental ...
(Date:3/26/2015)... WA (PRWEB) March 26, 2015 Dr. Bryan ... to announce his new March special. With spring ... of his Bellevue patients, he wants them to look and ... 20% off ZO Skincare products and any facial treatments when ... , To claim the deal and start getting radiant and ...
(Date:3/26/2015)... Utah (PRWEB) March 26, 2015 With more ... revenue days, doTERRA is dominating the essential oils industry. And ... they are building strong roots at home in Utah County. ... Valley Business of the Year by the Utah Valley ... the Mayor’s award and has now been awarded ...
Breaking Medicine News(10 mins):Health News:Albuquerque Area Mom Enters Mrs. New Mexico Pageant to Help Fight Pulmonary Hypertension 2Health News:Tom Fleming named Chairman of the Board and Robert Casares as Vice-Chairman of the Board of LinkToBanking 2Health News:Tom Fleming named Chairman of the Board and Robert Casares as Vice-Chairman of the Board of LinkToBanking 3Health News:Hamlin Dental Group is Now Accepting New Patients and Offering a New Patient Special 2Health News:Dr. Bryan McIntosh Offers March Special on ZO Skincare and Facial Services 2Health News:doTERRA Named Utah Valley Business of the Year by BusinessQ 2Health News:doTERRA Named Utah Valley Business of the Year by BusinessQ 3
... lung cancer afflicts some smokers and not others, according to ... Annual Meeting 2009. , "A history of smoking has always ... it is actually not very accurate," said Jian-Min Yuan, Ph.D., ... Minnesota. "Smoking absolutely increases your risk, but why it does ...
... Those with higher levels of a compound had nearly 9 ... News) -- Someday, a simple urine test might spot ... The research is still in its preliminary stages, and it ... But if it works, the urine-based screen could give added ...
... of the Neuroscience Center of Excellence, Boyd Professor, and ... Degenerative Diseases Research at LSU Health Sciences Center New ... omega three fatty acid in the diet protects brain ... from a gene mutation in neurodegenerative diseases like Parkinson,s ...
... recently released study led by Joseph A. Roscoe, Ph.D. ... American Cancer Society and the National Cancer Society concludes ... associated with radiation-therapy used to treat cancer patients. ... P6 acupressure point on each wrist. This all ...
... travelers and shift workers, study suggests , , FRIDAY, April ... caused by disruption of internal clocks in two neural ... treatments, say U.S. researchers. , The University of Washington ... but linked, groups of neurons in a brain structure ...
... Dow Jones VentureSource: Investment at Lowest Level Since 1998, ... Concentrating on Established Companies SAN FRANCISCO and NEW ... VentureSource shows that the U.S. venture capital industry continued ... Venture capitalists invested just $3.90 billion in U.S. companies ...
Cached Medicine News:Health News:Urine test may determine if a smoker is at risk for lung cancer 2Health News:Urine Test Could Gauge Smokers' Lung Cancer Risk 2Health News:LSUHSC research shows fish oil protects against diseases like Parkinson's 2Health News:Relief Is Available for Cancer Patients Suffering from Radiation Therapy-Related Nausea 2Health News:Jet Lag Upsets Brain's Internal Clocks 2Health News:U.S. Venture Investment Lowest in 11 Years, Down 50% to $3.9 Billion in First Quarter 2Health News:U.S. Venture Investment Lowest in 11 Years, Down 50% to $3.9 Billion in First Quarter 3Health News:U.S. Venture Investment Lowest in 11 Years, Down 50% to $3.9 Billion in First Quarter 4Health News:U.S. Venture Investment Lowest in 11 Years, Down 50% to $3.9 Billion in First Quarter 5
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
Medicine Products: